- Clinical Trials
- Research News
- Industry Trends
- Agency Actions
- Drug Safety Issues
- Approvals, Launches, & New Indications
- Health Care Reform
FDA Approves Epaned, Liquid Form of Enalapril, for Hypertension in Children and Adults
Product can be used in children as young as 1 month (August 14)
The FDA has approved Epaned (enalapril maleate powder for oral solution) to treat hypertension in children and adults aged 1 month and older. Enalapril — an angiotensin-converting enzyme (ACE) inhibitor — is one of the most commonly prescribed medicines in the U.S. to treat hypertension.
According to the product’s manufacturer (Silvergate Pharmaceuticals), Epaned allows accurate dosing for children who until now have relied on an adjusted adult dose. In addition, anyone who has difficulty swallowing enalapril tablets may respond well to the liquid formulation.
According to the International Pediatric Hypertension Association, the effects of hypertension can begin during childhood. Children with high blood pressure tend to have other medical problems, such as obesity, high blood lipids, and/or diabetes mellitus. In addition, children with hypertension tend to have the disorder as adults.
Source: PipelineReview.com; August 14, 2013.